NURIX THERAPEUTICS, INC. (NRIX) scores 43 out of 100 on boothcheck's 11-model valuation framework. Verdict: Poor The estimated fair value is 0.38, representing a 98% premium to fair value. Quantitative score: 47/100. Qualitative score: 60/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.